Dyslexia Treatments Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Drug Type (Cyclizine, Meclizine, Methylphenidate, Dimenhydrinate); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
Report Code: TIPRE00007747 No. of Pages: 151 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Dyslexia is a neurological disorder that leads to difficulty in reading, writing, and remembering the difficult words. Dyslexia is present at birth and cannot be cured or prevented, but can be managed with special instruction and support. Different apps have are there to improve the memory of patients like online programs, and visual & audio tools and instruments and devices.
MARKET DYNAMICS
The dyslexia treatment market is anticipated to grow in the market by various factors such as increased public health care products on mental health drives the market growth. However, the low awareness about the diagnosis and treatment of dyslexia, and the inefficient mental health infrastructure is projected to restrain the growth of the global dyslexia treatment market. Moreover, the large number of research institutes supporting dyslexia treatment is driving the growth of the market.
MARKET SCOPE
The "Dyslexia Treatments Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in dyslexia treatments market with detailed market segmentation by drug type, distribution channel and geography. The dyslexia treatments market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in dyslexia treatments market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The dyslexia treatments market is segmented on the basis of drug type and distribution channel. Based on drug type the market is segmented as cyclizine, meclizine, methylphenidate and dimenhydrinate. On the basis of distribution channel the market is categorized as hospital pharmacies, retail pharmacies and online pharmacies.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in dyslexia treatments market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The dyslexia treatments market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting dyslexia treatments market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the dyslexia treatments market in these regions.
The report covers key developments in the in dyslexia treatments market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in dyslexia treatments market are anticipated to have lucrative growth opportunities in the future with the rising demand for in dyslexia treatments market in the global market. Below mentioned is the list of few companies engaged in the in dyslexia treatments market.
The report also includes the profiles of key in dyslexia treatments market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Dyslexia is a neurological disorder that leads to difficulty in reading, writing, and remembering the difficult words. Dyslexia is present at birth and cannot be cured or prevented, but can be managed with special instruction and support. Different apps have are there to improve the memory of patients like online programs, and visual & audio tools and instruments and devices.
MARKET DYNAMICS
The dyslexia treatment market is anticipated to grow in the market by various factors such as increased public health care products on mental health drives the market growth. However, the low awareness about the diagnosis and treatment of dyslexia, and the inefficient mental health infrastructure is projected to restrain the growth of the global dyslexia treatment market. Moreover, the large number of research institutes supporting dyslexia treatment is driving the growth of the market.
MARKET SCOPE
The "Dyslexia Treatments Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in dyslexia treatments market with detailed market segmentation by drug type, distribution channel and geography. The dyslexia treatments market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in dyslexia treatments market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The dyslexia treatments market is segmented on the basis of drug type and distribution channel. Based on drug type the market is segmented as cyclizine, meclizine, methylphenidate and dimenhydrinate. On the basis of distribution channel the market is categorized as hospital pharmacies, retail pharmacies and online pharmacies.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in dyslexia treatments market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The dyslexia treatments market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting dyslexia treatments market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the dyslexia treatments market in these regions.
The report covers key developments in the in dyslexia treatments market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in dyslexia treatments market are anticipated to have lucrative growth opportunities in the future with the rising demand for in dyslexia treatments market in the global market. Below mentioned is the list of few companies engaged in the in dyslexia treatments market.
The report also includes the profiles of key in dyslexia treatments market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Gangwal Chemicals Pvt. Ltd
- GlaxoSmithKline
- Jubilant Cadista
- Micro Labs
- Novartis AG
- Pfizer Inc.
- Purdue Pharma
- RPG Life Sciences Ltd
- Srikem Labs
- Wallace Pharmaceuticals Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Dyslexia Treatment Market - By Drug Type
1.3.2 Dyslexia Treatment Market - By Distribution Channel
1.3.3 Dyslexia Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DYSLEXIA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DYSLEXIA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. DYSLEXIA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. DYSLEXIA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. DYSLEXIA TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DYSLEXIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. CYCLIZINE
7.3.1. Overview
7.3.2. Cyclizine Market Forecast and Analysis
7.4. MECLIZINE
7.4.1. Overview
7.4.2. Meclizine Market Forecast and Analysis
7.5. METHYLPHENIDATE
7.5.1. Overview
7.5.2. Methylphenidate Market Forecast and Analysis
7.6. DIMENHYDRINATE
7.6.1. Overview
7.6.2. Dimenhydrinate Market Forecast and Analysis
8. DYSLEXIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis
9. DYSLEXIA TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Dyslexia Treatment Market Overview
9.1.2 North America Dyslexia Treatment Market Forecasts and Analysis
9.1.3 North America Dyslexia Treatment Market Forecasts and Analysis - By Drug Type
9.1.4 North America Dyslexia Treatment Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Dyslexia Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Dyslexia Treatment Market
9.1.5.1.1 United States Dyslexia Treatment Market by Drug Type
9.1.5.1.2 United States Dyslexia Treatment Market by Distribution Channel
9.1.5.2 Canada Dyslexia Treatment Market
9.1.5.2.1 Canada Dyslexia Treatment Market by Drug Type
9.1.5.2.2 Canada Dyslexia Treatment Market by Distribution Channel
9.1.5.3 Mexico Dyslexia Treatment Market
9.1.5.3.1 Mexico Dyslexia Treatment Market by Drug Type
9.1.5.3.2 Mexico Dyslexia Treatment Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Dyslexia Treatment Market Overview
9.2.2 Europe Dyslexia Treatment Market Forecasts and Analysis
9.2.3 Europe Dyslexia Treatment Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Dyslexia Treatment Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Dyslexia Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Dyslexia Treatment Market
9.2.5.1.1 Germany Dyslexia Treatment Market by Drug Type
9.2.5.1.2 Germany Dyslexia Treatment Market by Distribution Channel
9.2.5.2 France Dyslexia Treatment Market
9.2.5.2.1 France Dyslexia Treatment Market by Drug Type
9.2.5.2.2 France Dyslexia Treatment Market by Distribution Channel
9.2.5.3 Italy Dyslexia Treatment Market
9.2.5.3.1 Italy Dyslexia Treatment Market by Drug Type
9.2.5.3.2 Italy Dyslexia Treatment Market by Distribution Channel
9.2.5.4 Spain Dyslexia Treatment Market
9.2.5.4.1 Spain Dyslexia Treatment Market by Drug Type
9.2.5.4.2 Spain Dyslexia Treatment Market by Distribution Channel
9.2.5.5 United Kingdom Dyslexia Treatment Market
9.2.5.5.1 United Kingdom Dyslexia Treatment Market by Drug Type
9.2.5.5.2 United Kingdom Dyslexia Treatment Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Dyslexia Treatment Market Overview
9.3.2 Asia-Pacific Dyslexia Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Dyslexia Treatment Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Dyslexia Treatment Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Dyslexia Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Dyslexia Treatment Market
9.3.5.1.1 Australia Dyslexia Treatment Market by Drug Type
9.3.5.1.2 Australia Dyslexia Treatment Market by Distribution Channel
9.3.5.2 China Dyslexia Treatment Market
9.3.5.2.1 China Dyslexia Treatment Market by Drug Type
9.3.5.2.2 China Dyslexia Treatment Market by Distribution Channel
9.3.5.3 India Dyslexia Treatment Market
9.3.5.3.1 India Dyslexia Treatment Market by Drug Type
9.3.5.3.2 India Dyslexia Treatment Market by Distribution Channel
9.3.5.4 Japan Dyslexia Treatment Market
9.3.5.4.1 Japan Dyslexia Treatment Market by Drug Type
9.3.5.4.2 Japan Dyslexia Treatment Market by Distribution Channel
9.3.5.5 South Korea Dyslexia Treatment Market
9.3.5.5.1 South Korea Dyslexia Treatment Market by Drug Type
9.3.5.5.2 South Korea Dyslexia Treatment Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Dyslexia Treatment Market Overview
9.4.2 Middle East and Africa Dyslexia Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Dyslexia Treatment Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Dyslexia Treatment Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Dyslexia Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Dyslexia Treatment Market
9.4.5.1.1 South Africa Dyslexia Treatment Market by Drug Type
9.4.5.1.2 South Africa Dyslexia Treatment Market by Distribution Channel
9.4.5.2 Saudi Arabia Dyslexia Treatment Market
9.4.5.2.1 Saudi Arabia Dyslexia Treatment Market by Drug Type
9.4.5.2.2 Saudi Arabia Dyslexia Treatment Market by Distribution Channel
9.4.5.3 U.A.E Dyslexia Treatment Market
9.4.5.3.1 U.A.E Dyslexia Treatment Market by Drug Type
9.4.5.3.2 U.A.E Dyslexia Treatment Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Dyslexia Treatment Market Overview
9.5.2 South and Central America Dyslexia Treatment Market Forecasts and Analysis
9.5.3 South and Central America Dyslexia Treatment Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Dyslexia Treatment Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Dyslexia Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Dyslexia Treatment Market
9.5.5.1.1 Brazil Dyslexia Treatment Market by Drug Type
9.5.5.1.2 Brazil Dyslexia Treatment Market by Distribution Channel
9.5.5.2 Argentina Dyslexia Treatment Market
9.5.5.2.1 Argentina Dyslexia Treatment Market by Drug Type
9.5.5.2.2 Argentina Dyslexia Treatment Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. DYSLEXIA TREATMENT MARKET, KEY COMPANY PROFILES
11.1. GANGWAL CHEMICALS PVT. LTD
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GLAXOSMITHKLINE
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. JUBILANT CADISTA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MICRO LABS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NOVARTIS AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PURDUE PHARMA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. RPG LIFE SCIENCES LTD
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SRIKEM LABS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. WALLACE PHARMACEUTICALS LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Dyslexia Treatment Market - By Drug Type
1.3.2 Dyslexia Treatment Market - By Distribution Channel
1.3.3 Dyslexia Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DYSLEXIA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DYSLEXIA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. DYSLEXIA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. DYSLEXIA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. DYSLEXIA TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DYSLEXIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. CYCLIZINE
7.3.1. Overview
7.3.2. Cyclizine Market Forecast and Analysis
7.4. MECLIZINE
7.4.1. Overview
7.4.2. Meclizine Market Forecast and Analysis
7.5. METHYLPHENIDATE
7.5.1. Overview
7.5.2. Methylphenidate Market Forecast and Analysis
7.6. DIMENHYDRINATE
7.6.1. Overview
7.6.2. Dimenhydrinate Market Forecast and Analysis
8. DYSLEXIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis
9. DYSLEXIA TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Dyslexia Treatment Market Overview
9.1.2 North America Dyslexia Treatment Market Forecasts and Analysis
9.1.3 North America Dyslexia Treatment Market Forecasts and Analysis - By Drug Type
9.1.4 North America Dyslexia Treatment Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Dyslexia Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Dyslexia Treatment Market
9.1.5.1.1 United States Dyslexia Treatment Market by Drug Type
9.1.5.1.2 United States Dyslexia Treatment Market by Distribution Channel
9.1.5.2 Canada Dyslexia Treatment Market
9.1.5.2.1 Canada Dyslexia Treatment Market by Drug Type
9.1.5.2.2 Canada Dyslexia Treatment Market by Distribution Channel
9.1.5.3 Mexico Dyslexia Treatment Market
9.1.5.3.1 Mexico Dyslexia Treatment Market by Drug Type
9.1.5.3.2 Mexico Dyslexia Treatment Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Dyslexia Treatment Market Overview
9.2.2 Europe Dyslexia Treatment Market Forecasts and Analysis
9.2.3 Europe Dyslexia Treatment Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Dyslexia Treatment Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Dyslexia Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Dyslexia Treatment Market
9.2.5.1.1 Germany Dyslexia Treatment Market by Drug Type
9.2.5.1.2 Germany Dyslexia Treatment Market by Distribution Channel
9.2.5.2 France Dyslexia Treatment Market
9.2.5.2.1 France Dyslexia Treatment Market by Drug Type
9.2.5.2.2 France Dyslexia Treatment Market by Distribution Channel
9.2.5.3 Italy Dyslexia Treatment Market
9.2.5.3.1 Italy Dyslexia Treatment Market by Drug Type
9.2.5.3.2 Italy Dyslexia Treatment Market by Distribution Channel
9.2.5.4 Spain Dyslexia Treatment Market
9.2.5.4.1 Spain Dyslexia Treatment Market by Drug Type
9.2.5.4.2 Spain Dyslexia Treatment Market by Distribution Channel
9.2.5.5 United Kingdom Dyslexia Treatment Market
9.2.5.5.1 United Kingdom Dyslexia Treatment Market by Drug Type
9.2.5.5.2 United Kingdom Dyslexia Treatment Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Dyslexia Treatment Market Overview
9.3.2 Asia-Pacific Dyslexia Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Dyslexia Treatment Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Dyslexia Treatment Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Dyslexia Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Dyslexia Treatment Market
9.3.5.1.1 Australia Dyslexia Treatment Market by Drug Type
9.3.5.1.2 Australia Dyslexia Treatment Market by Distribution Channel
9.3.5.2 China Dyslexia Treatment Market
9.3.5.2.1 China Dyslexia Treatment Market by Drug Type
9.3.5.2.2 China Dyslexia Treatment Market by Distribution Channel
9.3.5.3 India Dyslexia Treatment Market
9.3.5.3.1 India Dyslexia Treatment Market by Drug Type
9.3.5.3.2 India Dyslexia Treatment Market by Distribution Channel
9.3.5.4 Japan Dyslexia Treatment Market
9.3.5.4.1 Japan Dyslexia Treatment Market by Drug Type
9.3.5.4.2 Japan Dyslexia Treatment Market by Distribution Channel
9.3.5.5 South Korea Dyslexia Treatment Market
9.3.5.5.1 South Korea Dyslexia Treatment Market by Drug Type
9.3.5.5.2 South Korea Dyslexia Treatment Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Dyslexia Treatment Market Overview
9.4.2 Middle East and Africa Dyslexia Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Dyslexia Treatment Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Dyslexia Treatment Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Dyslexia Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Dyslexia Treatment Market
9.4.5.1.1 South Africa Dyslexia Treatment Market by Drug Type
9.4.5.1.2 South Africa Dyslexia Treatment Market by Distribution Channel
9.4.5.2 Saudi Arabia Dyslexia Treatment Market
9.4.5.2.1 Saudi Arabia Dyslexia Treatment Market by Drug Type
9.4.5.2.2 Saudi Arabia Dyslexia Treatment Market by Distribution Channel
9.4.5.3 U.A.E Dyslexia Treatment Market
9.4.5.3.1 U.A.E Dyslexia Treatment Market by Drug Type
9.4.5.3.2 U.A.E Dyslexia Treatment Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Dyslexia Treatment Market Overview
9.5.2 South and Central America Dyslexia Treatment Market Forecasts and Analysis
9.5.3 South and Central America Dyslexia Treatment Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Dyslexia Treatment Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Dyslexia Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Dyslexia Treatment Market
9.5.5.1.1 Brazil Dyslexia Treatment Market by Drug Type
9.5.5.1.2 Brazil Dyslexia Treatment Market by Distribution Channel
9.5.5.2 Argentina Dyslexia Treatment Market
9.5.5.2.1 Argentina Dyslexia Treatment Market by Drug Type
9.5.5.2.2 Argentina Dyslexia Treatment Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. DYSLEXIA TREATMENT MARKET, KEY COMPANY PROFILES
11.1. GANGWAL CHEMICALS PVT. LTD
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GLAXOSMITHKLINE
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. JUBILANT CADISTA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MICRO LABS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NOVARTIS AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PURDUE PHARMA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. RPG LIFE SCIENCES LTD
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SRIKEM LABS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. WALLACE PHARMACEUTICALS LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Gangwal Chemicals Pvt. Ltd
2. GlaxoSmithKline
3. Jubilant Cadista
4. Micro Labs
5. Novartis AG
6. Pfizer Inc.
7. Purdue Pharma
8. RPG Life Sciences Ltd
9. Srikem Labs
10. Wallace Pharmaceuticals Ltd.
1. Gangwal Chemicals Pvt. Ltd
2. GlaxoSmithKline
3. Jubilant Cadista
4. Micro Labs
5. Novartis AG
6. Pfizer Inc.
7. Purdue Pharma
8. RPG Life Sciences Ltd
9. Srikem Labs
10. Wallace Pharmaceuticals Ltd.